29 September 2021 | News
The medtech startup plans to expand services to 1,000 hospitals globally by 2023
Indian medtech startup, NeuroEquilibrium, has secured European CE Mark regulatory approvals for its innovative diagnostic products. NeuroEquilibrium plans to expand its Advanced Dizziness and Balance Lab Services to 1,000 hospitals globally by 2023.
"The patented and innovative technology of NeuroEquilibrium got a real shot in the arm with the grant of the sixth patent in India and second patent in the US. It is a trend reversal, Indian companies looked for imported products and solutions, but now Indian innovators are going global with unique and path-breaking MedTech Products and solutions," said Rajneesh Bhandari, Founder, NeuroEquilibrium who is an IIT alumnus and a serial entrepreneur.
Recently, NeuroEquilibrium has supplied its Vertigo and Dizziness lab to prestigious institutions like AIIMS Delhi, AIIMS Raipur, and ISRO, which will help the common man suffering from dizziness and balance disorders.